Shares in Tandem Diabetes Care (NSDQ:TNDM) fell yesterday after the medical device maker missed sales expectations but beat EPS estimates on Wall Street with its second quarter results.
The San Diego, Calif.-based company posted a loss of -$21.8 million, or -44¢ per share, on sales of $21.3 million for the 3 months ended June 30, for bottom-line loss of -19% on sales loss of -7% compared with the same period last year.
Get the full story at our sister site, Drug Delivery Business News.
The post Tandem shares slide after Q2 sales miss appeared first on MassDevice.